ChemComm
Communication
Table 2 Biocatalytic deracemization of various racemic 2-HAs in one-pot con- 1.5 with 6.0 M HCl and the desired product was extracted with 1.0 L of
a
current catalysis
ethylacetate. The extract obtained was concentrated under reduced
pressure and yielded 3.18 g of (R)-1b (99.5% ee, 90% isolated yield).
The results confirmed that deracemization of racemic 2-HAs in a one-
pot, single-step oxidation–reduction process by combination of resting
cells of P. aeruginosa CCTCC M 2011394 and S. cerevisiae ZJB5074 for
production of (R)-2-HAs was feasible in practical applications.
Deracemization of racemic 2-HAs to (R)-2-HAs was successfully
realized via concurrent asymmetric oxidation and stereoselective
reduction employing two resting-cell biocatalysts. One biocatalyst
was P. aeruginosa CCTCC M 2011394 which catalyzed the stereo-
selective oxidation of (S)-2-HAs to corresponding 2-ketoacids and
b
c
Entry Substrate
X
n
Time (h) (R)-1 (%) ee (%)
another was S. cerevisiae ZJB5074 which reduced the 2-ketoacids to
R)-2-HAs. This proposed one-pot, single-step deracemization
1
2
3
4
5
6
7
8
9
1
1
1
1
1
1
1
1
rac-1a
rac-1b
rac-1c
rac-1d
rac-1e
rac-1f
rac-1g
rac-1h
rac-1i
rac-1j
rac-1k
rac-1l
rac-1m
rac-1n
rac-1o
rac-1p
rac-1q
H
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
2
25
24
33
33
25
24
24
24
33
21
24
27
30
21
27
24
33
92.67
98.67
90.94
92.65
92.46
92.15
98.53
93.43
85.29
62.24
65.59
75.09
67.65
55.91
79.64
60.95
66.69
99.9
99.5
99.9
99.9
99.9
99.9
99.9
99.9
99.9
99.9
99.9
99.9
99.9
98.7
99.9
99.5
99.3
(
2-Cl
3-Cl
4-Cl
2-F
method leads to the development of a new tool for the preparation
of (R)-2-HAs.
Financial support from NSFC (No. 31170761), ‘‘973’’ Project
4-F
(
2011CB710806), ‘‘863’’ Project (2011AA02A210) and the Key Inno-
vation Research Group Programs of Zhejiang Province (No.
011R09043) is gratefully acknowledged. We would like to thank
2,4-F
3,5-F
4-Br
3-OH
4-OH
4-CH
4-OCH
3-OCH
2
0
1
2
3
4
5
6
7
Dr Mingjie Jin from Michigan State University for his assistance.
3
3
Notes and references
3
-4-OH
4-CF
H
H
3
1
M. Schober, M. Toesch, T. Knaus, G. A. Strohmeier, B. van Loo,
M. Fuchs, F. Hollfelder, P. Macheroux and K. Faber, Angew. Chem.,
Int. Ed., 2013, 52, 3277; R. Azerad and D. Buisson, Curr. Opin.
Biotechnol., 2000, 11, 565.
a
Reaction conditions: 10 gdcw per L P. aeruginosa CCTCC M 2011394,
À1
5
gdcw per L S. cerevisiae ZJB5074, 20 mM racemic 1a–1q, 10 g L glycerol,
2 M. Hall and A. S. Bommarius, Chem. Rev., 2011, 111, 4088.
3 C. H. Wong, S. T. Chen, W. J. Hennen, J. A. Bibbs, Y. F. Wang, J. L. C.
Liu, M. W. Pantoliano, M. Whitlow and P. N. Bryan, J. Am. Chem.
Soc., 1990, 112, 945; H. Y. Lu, J. Chen, Y. G. Zheng and Y. C. Shen,
Mod. Chem. Ind., 2007, 27, 66; H. R. Huang, J. H. Xu, Y. Xu, J. Pan
and X. Liu, Tetrahedron: Asymmetry, 2005, 16, 2113; G. D. Yadav and
P. Sivakumar, Biochem. Eng. J., 2004, 19, 101; W. Adam, M. Lazarus,
B. Boss, C. R. Saha-M ¨o ller, H.-U. Humpf and P. Schreier, J. Org.
Chem., 1997, 62, 7841; H. Groger, Adv. Synth. Catal., 2001, 343, 547.
b
pH 7.5 (potassium phosphate, 100 mM), 30 1C, 180 rpm. Conversion of
c
(
R)-1, determined by chiral RP-HPLC. The ee value of (R)-1.
As the process of concurrent catalysis was quite efficient, bio-
catalytic deracemization of a range of 2-HAs was performed in a one-
pot, single-step procedure. The results are given in Table 2. For
deracemization of 1a–1i (Table 2, entries 1–9), the enantiomeric
R)-2-HAs were obtained with high stereo-selectivities (>99% ee) and
high yields (85.29–98.67%) within 24–33 h. In the case of 1j–1q
Table 2, entries 10–17), (R)-2-HAs were obtained with high enantio-
selectivities (>99% ee) and moderate yields (55.91–79.64%) within
1–33 h. Overall, a variety of enantiopure (R)-2-HAs were successfully
4
5
T. M. Beard and N. J. Turner, Chem. Commun., 2002, 246.
A. Goswami, K. D. Mirfakhrae and R. N. Patel, Tetrahedron: Asymmetry,
1999, 10, 4239.
(
6
C. V. Voss, C. C. Gruber, K. Faber, T. Knaus, P. Macheroux and
W. Kroutil, J. Am. Chem. Soc., 2008, 130, 13969; C. V. Voss, C. C.
Gruber and W. Kroutil, Angew. Chem., Int. Ed., 2008, 47, 741; Y.-L. Li,
J.-H. Xu and Y. Xu, J. Mol. Catal. B: Enzym., 2010, 64, 48; G. Fantin,
M. Fogagnolo, P. P. Giovannini, A. Medici and P. Pedrini, Tetra-
hedron: Asymmetry, 1995, 6, 3047.
(
2
prepared in a one-pot and single-step procedure with good yield and
excellent ee. Deracemization by stereoinversion in one-pot concurrent
catalysis thus overcomes the limitation of the maximum theoretical
yield of 50% encountered during kinetic resolution of racemic 2-HAs.
This method represents an easy, cheap and environmentally benign
way for the biocatalytic synthesis of chiral 2-HAs from their racemates.
To further evaluate the feasibility of the bioprocess for production
of (R)-HAs for practical application, a 1.0 L scale one-pot concurrent
reaction system for the deracemization of 1b under the above-
mentioned conditions was performed in a 2.0 L stirred-tank reactor.
7
8
9
G. Shin, S. Mathew, M. Shon, B.-G. Kim and H. Yun, Chem.
Commun., 2013, 49, 8629.
J. H. Schrittwieser, J. Sattler, V. Resch, F. G. Mutti and W. Kroutil,
Curr. Opin. Chem. Biol., 2011, 15, 249.
W. Adam, M. Lazarus, C. R. Saha-M ¨o ller and P. Schreier, Tetrahedron:
Asymmetry, 1998, 9, 351.
1
1
0 S. Tsuchiya, K. Miyamoto and H. Ohta, Biotechnol. Lett., 1992, 14, 1137.
1 Y. P. Xue, W. Wang, Y. J. Wang, Z. Q. Liu, Y. G. Zheng and Y. C. Shen,
Bioprocess Biosyst. Eng., 2012, 35, 1515; Y. P. Xue, Y. Q. Zhang,
W. Wang, Y. J. Wang, Z. Q. Liu, S. P. Zou, Y. G. Zheng and Y. C. Shen,
Bioresour. Technol., 2013, 132, 391.
12 Y. P. Xue, F. F. Tian, L. T. Ruan, Z. Q. Liu, Y. G. Zheng and
Y. C. Shen, J. Biotechnol., 2013, 167, 271.
(
R)-1b is one of the most preferred chiral building block for the 13 J. Guo, X. Mu, C. Zheng and Y. Xu, J. Chem. Technol. Biotechnol.,
2
009, 84, 1787.
4 K. Goldberg, K. Schroer, S. L u¨ tz and A. Liese, Appl. Microbiol. Biotechnol.,
007, 76, 249; J. D. Carballeira, M. A. Quezada, P. Hoyos, Y. Sime ´o , M. J.
industrial synthesis of the anti-thrombotic agent, (S)-clopidogrel,
1
17
which has been commercialized with a brand name, Plavix. The
process of deracemization was monitored by RP-HPLC, and it was
stopped at 24 h. The conversion and ee of (R)-1b were 94.7% and
2
Hernaiz, A. R. Alcantara and J. V. Sinisterra, Biotechnol. Adv., 2009, 27, 686.
5 I. Hilker, M. C. Gutierrez, R. Furstoss, J. Ward, R. Wohlgemuth and
V. Alphand, Nat. Protocols, 2008, 3, 546.
1
1
9
9.5%, respectively. The resting cells in the reaction mixture were
6 V. Massey, J. Biol. Chem., 1994, 269, 22459.
removed by centrifugation. The pH of the supernatant was adjusted to 17 A. Bousquet and A. Musolino, US pat, 6573381 B1, 2003.
This journal is c The Royal Society of Chemistry 2013
Chem. Commun.